PER — Percheron Therapeutics Share News
0.000.00%
- AU$6.09m
- AU$2.07m
- AU$0.15m
Australia Stock Exchange release from ANTISENSE THERAP : Dosing commenced in MCRI collaboration animal study
Australia Stock Exchange release from ANTISENSE THERAP : Cleansing Notice
Australia Stock Exchange release from ANTISENSE THERAP : Application for quotation of securities - ANP
Australia Stock Exchange release from ANTISENSE THERAP : Proposed issue of securities - ANP
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 09:22:50
Australia Stock Exchange release from ANTISENSE THERAP : Quarterly Report and Appendix 4C
Australia Stock Exchange release from ANTISENSE THERAP : Proposed issue of securities - ANP
Australia Stock Exchange release from ANTISENSE THERAP : Change of Director's Interest Notice (MD)
Australia Stock Exchange release from ANTISENSE THERAP : Notification regarding unquoted securities - ANP
Australia Stock Exchange release from ANTISENSE THERAP : Application for quotation of securities - ANP
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 10:01:11
Australia Stock Exchange release from ANTISENSE THERAP : Entitlement Offer Results
Australia Stock Exchange release from ANTISENSE THERAP : Appendix 3G
Australia Stock Exchange release from ANTISENSE THERAP : Final Director's Interest Notice (WG)
Australia Stock Exchange release from ANTISENSE THERAP : Final Director's Interest Notice (GM, RM)
Australia Stock Exchange release from ANTISENSE THERAP : Results of Annual General Meeting
Australia Stock Exchange release from ANTISENSE THERAP : Annual General Meeting Presentation
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 10:32:25
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 09:36:02